Abstract
Psychomotor disturbances (PMD) are a classic feature of depressive disorder that provides rich clinical information. The aim our narrative review was to characterize the functional anatomy of PMD by summarizing findings from neuroimaging studies. We found evidence across several neuroimaging modalities that suggest involvement of fronto-striatal neurocircuitry, and monoaminergic pathways and metabolism. We suggest that PMD in major depressive disorder emerge from an alteration of limbic signals, which influence emotion, volition, higher-order cognitive functions, and movement.
Introduction
Psychomotor signs are a classic feature of major depressive disorder that already attracted attention over a century ago (1). Emil Kraepelin gave a vivid and still valid description of psychomotor disturbances (PMD) in his chapter on general symptomatology in Lehrbuch des Psychiatrie, 1907: “The psychomotor retardation, which is the most important disturbance in the depressed states of manic-depressive insanity, is probably due to a […] increase in resistance […] In spite of every apparent exertion, the patients cannot utter a word or at best answer only in monosyllables, and are unable to eat, stand up, or dress. As a rule they clearly recognize the enormous pressure lying upon them, which they are unable to overcome” (2).
Psychomotor disturbances in depressive disorder can be broadly classified in to four subgroups of symptoms and signs based on three available clinical rating scales designed to characterize them [CORE, motor agitation and retardation scale (MARS), Widlöcher scale] (3–5): retardation, agitation, non-interactiveness, and mental slowing (Table 1). The symptoms and signs of PMD therefore entail a wide range of brain functions including motor performance, executive function, volition, and drive. These provide rich clinical information (i.e., diagnostic subgroup, prognosis, treatment) (6, 7).
Table 1
| Subgroup of psychomotor disturbances | Example |
|---|---|
| Retardation | Slowed movements (motor slowness), facial immobility (lack of facial expressivity, downcast gaze, reduced voice volume, slurring of speech), body immobility (immobility of trunk/proximal limbs), postural slumping (postural collapse), delay in motor activity, delay in responding verbally (delayed speech onset), slowing of speech rate (monotone speech), abnormal gait |
| Agitation | Frightened apprehension (static facial expression, abnormal staring, increased blinking, erratic eye movement), facial agitation (movement/tension in mouth), motor agitation (increased axial truncal movement), stereotyped movements (tension in fingers and hands, hand movement, foot/lower leg movement), verbal stereotypy |
| Non-interactiveness | Response to social cues, emotional responsiveness, inattentiveness, poverty of associations, spontaneous speech, length of verbal responses |
| Mental slowing | Language and verbal flow, variety of themes spontaneously approached, richness of associations, subjective experience of ruminations, fatigability, perception of flow of time, memory, concentration, interest in habitual activities |
Psychomotor signs in major depressive disorder.
No previous review has focused specifically on neuroimaging findings related to PMD in major depressive disorder. The aim of this narrative review is to characterize the functional anatomy of PMD in major depressive disorder by summarizing findings from human neuroimaging studies that probe structure, function, neurochemistry, and connectivity.
Structural Neuroimaging
Structural aberrations in white matter are the most prominent structural neuroimaging findings associated with PMD in depressive disorder.
White-matter alterations (hyperintensities, WHI; and white-matter fiber integrity), are one of the most reproduced findings in mood disorders. White-matter hyperintensities (WHIs) are radiological hyperintense regions of white matter with elusive etiology in MRI images. They are primarily associated with late-life depression, but are also more common in major depressive disorder in younger age groups. The extent of WHIs correlates with illness severity, poor treatment response, and decreased psychomotor speed on several neuropsychological tests (8). White-matter tissue broadly comprises glial cells with myelin surrounding axons. Currently, the general understanding is that the WHIs alterations observed in depression arise from small vessel disease that lead to disruption of white-matter pathways (9). However, other disease mechanisms involving white-matter tissue may also lead to disruptions of specific neurocircuits and lead to psychiatric symptoms such as PMD (10).
White-matter fiber integrity can be assessed with diffusion-weighted imaging. One study by Walther et al. (11) who specifically addressed psychomotor functioning in depressive disorder used diffusion-weighted magnetic resonance imaging and actigraphy – an objective measure of the general activity level in an individual. It showed that lower activity levels correlate with measures of differential myelinization in the frontal lobe and posterior cingulate region, and that there is a negative correlation between the same measures in the white matter beneath the primary motor cortex and in the parahippocampal region. The authors conclude that changes in psychomotor function in depressive disorder may be linked to changes in white matter in motor regions. Bracht et al. used diffusion-weighted imaging to investigate white-matter microstructure in relation to PMD. They found a positive association between decreased physical motor activity and alterations in paralimbic and motor midline regions not only involved in volitional movement but also involvement of ascending mesocortical dopamine pathways in clinical states with prominent PMD (12, 13).
To this date, few studies have investigated the relation between gray matter volume and PMD in major depressive disorder. Current findings involve volume reductions in several pre-executive parts of the motor system. One volumetric study showed that thinning of the right presupplementary motor cortex (pre-SMA) is associated with impaired performance on a motor learning test (14). The pre-SMA is a part of the mesial premotor cortex that advances signals from the prefrontal regions, engaged in higher-order cognitive functions. In studies measuring subcortical volumes and regional shape alterations, no significant associations could be found between performance on a psychomotor task (trail making test variations) and the volumes of striatum, pallidum, and thalamus in depressed subjects (15, 16). Another study found that reduced caudate nucleus volumes predicts decreased psychomotor speed in depressed subjects >50 years old (17).
Only one study, using CT, has assessed cerebrospinal fluid space size. This study found that the size of the third ventricle was associated with clinical ratings of psychomotor retardation (18).
Functional Neuroimaging
Blood–oxygen-level-dependent (BOLD) functional magnetic resonance imaging (fMRI) is currently the most prevalent method for studying neural activation patterns during experimental tasks in patients with depressive disorder. A few research teams have specifically addressed PMD using fMRI and experimental motor tasks, clinical ratings of psychomotor disturbance, or motor physiology metrics (i.e., actigraphy, reaction time). Two types of studies have been employed – task and non-task based studies. Naismith et al. (19) used a motor sequence task (button press response) to study motor learning, and found increased activation of lateral prefrontal cortex, superior temporal regions, and the cerebellum. Caligiuri et al. (20, 21) studied motor execution using a manual reaction time task, and found increased activation during movement in the primary motor cortex, alongside motor asymmetry. Five other studies investigated motor speed using different finger-tapping variations (22–27), and suggest an increased activation in both motor and paralimbic regions, and with altered fronto-striatal coupling among patients. One non-task, resting-state study, by Yao et al. (28) corroborates the hyperactivation of paralimbic regions in patients.
Electroencephalography
Electroencephalography (EEG) is used to study power amplitude of particular frequency spectrums, hemisphere asymmetry, and chronometric features of cortical neural activation. PMD have been associated with greater variability and increased amplitudes in the delta (<4 Hz) and theta (4–7 Hz) spectrum, but not with hemisphere asymmetry (29). The post-imperative negative variation is a metric related to frontal lobe function, and has been associated with psychomotor slowing in a choice reaction task (30). Another frontal metric (P300) has also been correlated positively correlated with PMD (31). Interestingly, this study also showed that only clinical ratings more focused on PMD than the Hamilton depression ratings scale (HDRS) predicted P300 latency. In a group of patients receiving electroconvulsive treatment, clinical ratings of PMD were positively correlated with frequency decreases during initial improvement, whereas the reverse relationship was found during the later partial remission phase (32). One study by Nieber et al. (33) showed a positive correlation between decreased frequencies in particular regions of the theta and alpha (7–13 Hz) spectrum and overall retardation, with motor retardation, in particular. In that study, increased frequency in particular regions of in the alpha and beta spectrum was negatively correlated with PMD. Error-related negativity and positive-negativity are metrics associated with anterior and posterior cingulate cortex function, respectively (34, 35). These metrics have been associated with a slowing of psychomotor performance in subjects during action monitoring, but only positive-negativity differentiated patients and controls (36).
Molecular Neuroimaging
Single-photon emission tomography (SPECT), positron emission tomography (PET), and arterial spin labeling (ASL) are the three molecular neuroimaging methods that have been used to study PMD. These three methods measure regional cerebral blood flow, glucose metabolism, oxygen consumption, or synaptic transmission factors. Walther et al. (37) used ASL and actigraphy to measure the correlation between regional cerebral blood flow and general motor activity outside of the scanner environment in depressed subjects. The study showed a positive correlation between physical activity and blood perfusion in the right orbitofrontal cortex, and a negative correlation with left supplementary motor area perfusion. The available evidence from PET and SPECT studies also suggests that PMD in depression are associated with decreased DLPFC metabolism (38–40), increased ACC metabolism (41–43), and a lower dopaminergic tone and altered metabolism in striatal regions (41, 42, 44–47). However, a SPECT study by Graff-Guerrero et al. (48) failed to reproduce these associations between clinical rating of PMD and cerebral blood flow. One longitudinal study also suggests that improvement of psychomotor slowing is associated with increased activation in the dorsal ACC (49).
Transcranial Ultrasound
Hypo- or hyperechogenicity measured by transcranial sonography in vivo reflect changes in tissue impedance, likely due to alterations of microarchitecture such as shifts in cell density, changes in interstitial matrix composition, or alterations of fiber tract integrity (50, 51). Those transcranial ultrasound studies that have investigated PMD in major depression have focused on the serotonergic raphe nuclei and the dopaminergic substantia nigrae. A significantly reduced echogenicity of the mesencephalic midline raphe nuclei has been reported in depressed subjects (52). Hypoechogenicity of the raphe nuclei can be found in 50–70% of unipolar depressed subjects compared to 10% in healthy subjects (53). Hypoechogenicity of the raphe nuclei of the brain stem is associated with better treatment response to serotonin reuptake inhibitors (54) and with symptom severity in suicidal ideation (55). One study could not find any association between echogenicity of the raphe nuclei and PMD (51), another found a positive correlation with the degree of psychomotor retardation (56), and a third a negative correlation with psychomotor retardation (54). Hoeppner et al. showed that substantia nigra echogenic size correlates with motor asymmetry and reduced verbal fluency in unipolar depression. In that study, the association was stronger in patients ≥50 years, and in patients with reduced brain stem raphe nuclei hypogenicity (57).
Conclusion
In this review, we summarize the literature on the functional neuroanatomy of PMD in major depressive disorder (Table 2). Despite the clinical importance of PMD, we found relatively few studies. Indeed, the motor system has been relatively neglected in brain imaging studies of psychiatric disorders in general (58). We conclude that structural alterations that correlate with PMD have been found in gray- and white-matter regions within several nodes of cortico-subcortical circuits. Findings in functional neuroimaging studies show involvement of the same neurocircuitry nodes (along with their white-matter connections) as in structural neuroimaging studies, and further that limbic influences on the motor system may be important in the emergence of PMD. EEG studies suggest that frequency variations across many spectra, and an involvement of the frontal cortex, anterior, and posterior cingulate cortex, are associated with PMD. The molecular neuroimaging correlates of PMD resemble the functional anatomy of major depression described with functional and structural methods, but in addition also implicate disrupted monoamine transmission in PMD. The few available studies that use transcranial ultrasound primarily show an association between PMD and echogenic features of the substantia nigra, which then corroborates molecular neuroimaging findings of disrupted dopamine transmission.
Table 2
| Study | N | Diagnosis | Method | Measure | Finding | |
|---|---|---|---|---|---|---|
| Structural CT and MRI | Hickie et al. (8) | 39 | MDD | MRI (WMH) | Mean decision time | ↑ White-matter hyperintensities |
| Walther et al. (11) | 21 | MDD | DTI (FA) | Actigraphy | ↓ White-matter in motor regions | |
| Bracht et al. (12) | 21/21 | MDD | DTI (FA) | Actigraphy | ↓ White-matter in ACC and midline motor regions connected with PFC | |
| Bracht et al. (13) | 22/21 | MDD | DTI (FA) | Clinical features of PMD | ↓ White-matter in medial forebrain bundle | |
| Exner et al. (14) | 9 | MDD | MRI (ROI) | Serial reaction time task | ↓ pre-SMA volume | |
| Liberg et al. (15) | 27 | BPD | MRI (ROI, shape) | Trail Making Tests, reaction Time | No significant findings in the striatum, pallidum, and the thalamus | |
| Liberg et al. (16) | 20 | BPD | MRI (ROI, shape) | Trail Making Tests | No significant findings in the striatum, pallidum, and the thalamus | |
| Naismith et al. (17) | 47 | MDD | MRI (ROI) | Trail Making Test A | ↓ Right caudate volume | |
| Schlegel et al. (18) | 44 | MDD | CT, ventricle size | Bech–Rafaelsen Melancholia Scale | ↑ Lateral ventricle size | |
| fMRI | Naismith et al. (19) | 19/20 | MDD | Task-based fMRI | Motor sequencing task | ↑ Middle frontal gyrus, superior temporal gyrus, and cerebellum |
| Caligiuri et al. (20) | 24/13 | BPD | Task-based fMRI | Manual reaction time task | ↑ Right primary motor cortex in patients | |
| Caligiuri et al. (21) | 18/13 | BPD | Task-based fMRI | Manual reaction time task | ↑ Left primary motor area in patients. Motor asymmetry in patients with a failure to suppress right hemisphere activation during movement | |
| Marchand et al. (22) | 10 | BPD | Task-based fMRI | Finger-tapping | ↑ Right anterior cingulate cortex and medial frontal gyrus (euthymia > depression) | |
| Liberg et al. (24) | 9/12 | BPD | Task-based fMRI | Finger-tapping | No significant findings | |
| Liberg et al. (25) | 9/12 | BPD | Task-based fMRI | Finger-tapping, Motor imagery, CORE, AS-18 | ↓ Primary motor cortex, lateral ventral premotor cortex in relation to clinical ratings. ↑ Medial posterior parietal cortex during motor imagery. ↑ Fronto-parietal regions, and insular cortex, during motor execution | |
| Liberg et al. (26) | 13/13 | MDD | Task-based fMRI | Finger-tapping | ↓ Fronto-striatal coupling between cingulate motor area and putamen. ↑ Left cingulate motor area. ↑ Functional coupling and clinical ratings | |
| Marchand et al. (27) | 14/15 | BPD | Task-based fMRI | Finger-tapping | ↑ Left pre- and post-central gyrus, bilateral cingulate, right striatum, and left striatum, in patients | |
| Yao et al. (28) | 22/22 | MDD | Resting-state fMRI | HDRS | ↑ Regional homogeneity in right posterior cingulate cortex and right insula | |
| EEG | Nyström et al. (29) | 25 | MDD | EEG power spectrum analysis | Comprehensive Psychopatho-logical Rating Scale | ↑ Delta-, theta-amplitude, and variability |
| Thier et al. (30) | 11/11 | MDD | ERP | Serial choice reaction task | ↑ Post-imperative negative variation | |
| Schlegel et al. (31) | 36 | MDD | ERP | Bech–Rafaelsen Melancholia Scale | ↑ P300 latency | |
| Silfverskiöld et al. (32) | 21 | MDD | Global EEG frequency | Rating Scale for Affective Symptoms | ↓ Acute effects ↑ Non-acute effects | |
| Nieber et al. (33) | 63 | MDD | EEG power spectrum analysis | Bech–Rafaelsen Melancholia Scale | ↑ Slow activity ↓ Fast activity | |
| Schrijvers et al. (36) | 26 | MDD | ERP, Eriksen Flanker’s Task | Salpêtrière Retardation Rating Scale | ↑ Error-related negativity potentials | |
| Molecular neuroimaging | Walther et al. (37) | 20/19 | MDD | ASL | Wrist actigraphy | ↑ Right orbitofrontal cortex, ↓ left SMA |
| Bench et al. (38) | 40 | MDD | PET | HDRS | ↓ rCBF in left DLPFC, left parietal cortex | |
| Dolan et al. (39) | 40 | MDD | PET | HDRS | ↓ rCBF in left DLPFC | |
| Videbech et al. (40) | 42 | MDD | PET | HDRS | ↓ rCBF in DLPFC and OFC | |
| Milak et al. (41) | 298 | MDD | FDG-PET | HDRS | ↑ Metabolism in the cingulate gyrus, thalamus, and basal ganglia | |
| Dunn et al. (42) | 58 | MDD | FDG-PET | Beck’s Depression Inventory | ↓ Metabolism in right insula, claustrum, anteroventral caudate/putamen, and temporal cortex. | |
| ↑ Metabolism in ACC | ||||||
| Mayberg et al. (43) | 13 | MDD | 99mTc-SPECT | Finger-tapping | ↑ rCBF in paralimbic cortex (frontal and temporal) and prefrontal | |
| Meyer et al. (44) | 9/21 | MDD | RTI-32-PET | Finger-tapping | ↓ Dopamine transporter binding potential in striatum | |
| Meyer et al. (45) | 21 | MDD | Raclopride PET | Finger-tapping | ↑ Dopamine D2 receptor binding potential in the putamen | |
| Ebert et al. (46) | 20 | MDD | IBZM-SPECT | – | ↑ Striatal IBZM-BP | |
| Perico et al. (47) | 15 | MDD | 99mTc-SPECT | HDRS | ↑ Left premotor cortex and right anterior medial orbitofrontal cortex metabolism | |
| Graff-Guerrero et al. (48) | 14 | MDD | 99mTc-SPECT | HDRS | No significant correlation between retardation and CBF | |
| Brody et al. (49) | 39 | MDD | FDG-PET | HDRS | Improvement in psychomotor symptoms is associated with metabolism in dorsal ACC | |
| Transcranial sonography | Berg et al. (51) | 31 | PD with MDD | Ncl raphe | Columbia University Rating Scale | No significant correlation |
| Walter et al. (53) | 55 | MDD | Ncl raphe, substantia nigra | Unified Parkinson’s Disease Rating Scale (Motor part) | ↓ Raphe echogenicity, ↑ Substantia nigra echogenecity | |
| Walter et al. (54) | 52 | MDD | Ncl raphe | Motor Retardation and Agitation Scale | ↑ Raphe echogenecity | |
| Becker et al. (56) | 30 | PD with MDD | Ncl raphe | Columbia University Rating Scale | ↓ Raphe echogenecity | |
| Höppner et al. (57) | 45 | MDD | Substantia nigra | Finger-tapping (motor asymmetry), verbal fluency | ↑ Substantia nigra echogenic size |
Neuroimaging findings and their correlation to psychomotor disturbances.
ACC, anterior cingulate cortex; AS-18, affektiv skattningsskala 18 (59); ASL, arterial spin labeling; BP, binding potential; BPD, bipolar disorder depression; CT, computed tomography; DTI, diffusion tensor imaging; DLPFC, dorsolateral prefrontal cortex; EEG, electroencephalography; ERP, event-related potentials; FA, fractional anisotropy; FDG-PET, fluorodeoxyglucose positron emission tomography; fMRI, functional magnetic resonance imaging; HDRS, Hamilton Depression Rating Scale; IBZM, iodobenzamide single-photon emission computed tomography; MDD, major depressive disorder; MRI, magnetic resonance imaging; OFC, orbitofrontal cortex; PD, Parkinson’s disease; PET, positron emission tomography; ROI, region of interest; rCBF, regional cerebral blood flow; RTI-32, (1R-2-exo-3-exo)-8-methyl-3-(4-methylphenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate; SMA, supplementary motor area; SPECT, single-photon emission computed tomography; 99mTc, Technetium-99.
Structural and functional neuroimaging studies suggest that PMD involve alterations in large-scale cortico-striato-thalamo-cortical neurocircuits, and in particular fronto-striatal subdivisions. Findings from transcranial ultrasound, and molecular neuroimaging studies, suggest a putative underlying factor for these alterations in the form of disrupted influence of ascending dopamine tracts that emanate from deeper midbrain nuclei. This notion also fits with the broader picture of a depressive disorder with psychomotor disturbances, which also include alterations in cognitive function, drive, and emotional expression – phenomena that also map onto ascending monoamine tracts with targets in the frontal lobe. Taken together, the broad picture suggests that PMD in major depressive disorder emerges from altered limbic signals at the interface of emotion, volition, higher-order cognitive function, and movement.
Our review shows that PMD is an emerging field of research that has kept growing since over 20 years. However, the currently available studies also preclude firmer evidence when evaluated in the context of general research methodology. Most studies are cross-sectional, have <25 participants, and have not been reproduced. Furthermore, a wide variety of clinical psychomotor measures have been used. Thus, information about the anatomical specificity of PMD from future studies could be improved by the use of objective measurements of motor performance (i.e., finger-tapping, actigraphy) when investigating the different dimensions of PMD delineated by current clinical measurements (i.e., CORE, MARS), and using rating scales that probe PMD specifically. Further studies would also benefit from longitudinal experimental designs that disentangle the effects of brain changes on the functional components of PMD, and assess differences across neuropsychiatric disorders.
Statements
Acknowledgments
BL received funding from Svenska Läkaresällskapet (The Swedish Society of Medicine, SLS-403101), and the Strategic Research Committee, Karolinska Institutet/Stockholm County Council, Sweden. CR received funding from Schizofreniförbundet, Sweden. We also thank Dr. Caroline Wachtler for language revisions of the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
WellsFL. Motor retardation as a manic-depressive symptom. Am J Insanity (1909) LXVI(1):1–51.
2
KraepelinEDiefendorfAR. Clinical Psychiatry. (Vol. xvii). New York, NY: The Macmillan Company (1907). 562 p.
3
ParkerGHadzi-PavlovicDBrodatyHBoycePMitchellPWilhelmKet alPsychomotor disturbance in depression: defining the constructs. J Affect Disord (1993) 27(4):255–65.10.1016/0165-0327(93)90049-P
4
SobinCMayerLEndicottJ. The motor agitation and retardation scale: a scale for the assessment of motor abnormalities in depressed patients. J Neuropsychiatry Clin Neurosci (1998) 10(1):85–92.10.1176/jnp.10.1.85
5
WidlocherDJ. Psychomotor retardation: clinical, theoretical, and psychometric aspects. Psychiatr Clin North Am (1983) 6(1):27–40.
6
MalhiGSBerkM. Does dopamine dysfunction drive depression?Acta Psychiatr Scand Suppl (2007) 433:116–24.10.1111/j.1600-0447.2007.00969.x
7
MalhiGSParkerGBGreenwoodJ. Structural and functional models of depression: from sub-types to substrates. Acta Psychiatr Scand (2005) 111(2):94–105.10.1111/j.1600-0447.2004.00475.x
8
HickieIScottEMitchellPWilhelmKAustinMPBennettB. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry (1995) 37(3):151–60.10.1016/0006-3223(94)00174-2
9
WangLLeonardsCOSterzerPEbingerM. White matter lesions and depression: a systematic review and meta-analysis. J Psychiatr Res (2014) 56:56–64.10.1016/j.jpsychires.2014.05.005
10
NajjarSPearlmanDM. Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res (2015) 161(1):102–12.10.1016/j.schres.2014.04.041
11
WaltherSHugliSHofleOFederspielAHornHBrachtTet alFrontal white matter integrity is related to psychomotor retardation in major depression. Neurobiol Dis (2012) 47(1):13–9.10.1016/j.nbd.2012.03.019
12
BrachtTFederspielASchnellSHornHHofleOWiestRet alCortico-cortical white matter motor pathway microstructure is related to psychomotor retardation in major depressive disorder. PLoS One (2012) 7(12):e52238.10.1371/journal.pone.0052238
13
BrachtTHornHStrikWFederspielASchnellSHofleOet alWhite matter microstructure alterations of the medial forebrain bundle in melancholic depression. J Affect Disord (2014) 155:186–93.10.1016/j.jad.2013.10.048
14
ExnerCLangeCIrleE. Impaired implicit learning and reduced pre-supplementary motor cortex size in early-onset major depression with melancholic features. J Affect Disord (2009) 119(1–3):156–62.10.1016/j.jad.2009.03.015
15
LibergBEkmanCJSellgrenCJohanssonALandenM. Vertex-based morphometry in euthymic bipolar disorder implicates striatal regions involved in psychomotor function. Psychiatry Res (2014) 221(3):173–8.10.1016/j.pscychresns.2014.01.007
16
LibergBEkmanCJSellgrenCJohanssonAGLandenM. Subcortical morphometry and psychomotor function in euthymic bipolar disorder with a history of psychosis. Brain Imaging Behav (2014).10.1007/s11682-014-9313-0
17
NaismithSHickieIWardPBTurnerKScottELittleCet alCaudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression. Am J Psychiatry (2002) 159(12):2096–8.10.1176/appi.ajp.159.12.2096
18
SchlegelSMaierWPhilippMAldenhoffJBHeuserIKretzschmarKet alComputed tomography in depression: association between ventricular size and psychopathology. Psychiatry Res (1989) 29(2):221–30.10.1016/0165-1781(89)90037-1
19
NaismithSLLagopoulosJWardPBDaveyCGLittleCHickieIB. Fronto-striatal correlates of impaired implicit sequence learning in major depression: an fMRI study. J Affect Disord (2010) 125(1–3):256–61.10.1016/j.jad.2010.02.114
20
CaligiuriMPBrownGGMeloyMJEbersonSCKindermannSSFrankLRet alAn fMRI study of affective state and medication on cortical and subcortical brain regions during motor performance in bipolar disorder. Psychiatry Res (2003) 123(3):171–82.10.1016/S0925-4927(03)00075-1
21
CaligiuriMPBrownGGMeloyMJEylerLTKindermannSSEbersonSet alA functional magnetic resonance imaging study of cortical asymmetry in bipolar disorder. Bipolar Disord (2004) 6(3):183–96.10.1111/j.1399-5618.2004.00116.x
22
MarchandWRLeeJNThatcherJThatcherGWJensenCStarrJ. A preliminary longitudinal fMRI study of frontal-subcortical circuits in bipolar disorder using a paced motor activation paradigm. J Affect Disord (2007) 103(1–3):237–41.10.1016/j.jad.2007.01.008
23
MarchandWRLeeJNThatcherJWThatcherGWJensenCStarrJ. A longitudinal functional magnetic resonance imaging study of frontal-subcortical circuits in bipolar disorder using a paced motor activation paradigm. Bipolar Disord (2007) 9:74–5.
24
LibergBAdlerMJonssonTLandenMRahmCWahlundLOet alThe neural correlates of self-paced finger tapping in bipolar depression with motor retardation. Acta Neuropsychiatr (2013) 25(1):43–51.10.1111/j.1601-5215.2012.00659.x
25
LibergBAdlerMJonssonTLandenMRahmCWahlundLOet alMotor imagery in bipolar depression with slowed movement. J Nerv Ment Dis (2013) 201(10):885–93.10.1097/NMD.0b013e3182a5c2a7
26
LibergBKlauserPHardingIHAdlerMRahmCLundbergJet alFunctional and structural alterations in the cingulate motor area relate to decreased fronto-striatal coupling in major depressive disorder with psychomotor disturbances. Front Psychiatry (2014) 5:176.10.3389/fpsyt.2014.00176
27
MarchandWRLeeJNThatcherGWJensenCStewartDDildaVet alA functional MRI study of a paced motor activation task to evaluate frontal-subcortical circuit function in bipolar depression. Psychiatry Res (2007) 155(3):221–30.10.1016/j.pscychresns.2007.03.003
28
YaoZWangLLuQLiuHTengG. Regional homogeneity in depression and its relationship with separate depressive symptom clusters: a resting- state fMRI study. J Affect Disord (2009) 115(3):430–8.10.1016/j.jad.2008.10.013
29
NystromCMatousekMHallstromT. Relationships between EEG and clinical characteristics in major depressive disorder. Acta Psychiatr Scand (1986) 73(4):390–4.10.1111/j.1600-0447.1986.tb02700.x
30
ThierPAxmannDGiedkeH. Slow brain potentials and psychomotor retardation in depression. Electroencephalogr Clin Neurophysiol (1986) 63(6):570–81.10.1016/0013-4694(86)90144-6
31
SchlegelSNieberDHerrmannCBakauskiE. Latencies of the P300 component of the auditory event-related potential in depression are related to the Bech-Rafaelsen melancholia scale but not to the Hamilton rating scale for depression. Acta Psychiatr Scand (1991) 83(6):438–40.10.1111/j.1600-0447.1991.tb05571.x
32
SilfverskioldPRosenIRisbergJGustafsonL. Changes in psychiatric symptoms related to EEG and cerebral blood flow following electroconvulsive therapy in depression. Eur Arch Psychiatry Neurol Sci (1987) 236(4):195–201.10.1007/BF00383849
33
NieberDSchlegelS. Relationships between psychomotor retardation and EEG power spectrum in major depression. Neuropsychobiology (1992) 25(1):20–3.10.1159/000118804
34
MiltnerWHLemkeUWeissTHolroydCScheffersMKColesMG. Implementation of error-processing in the human anterior cingulate cortex: a source analysis of the magnetic equivalent of the error-related negativity. Biol Psychol (2003) 64(1–2):157–66.10.1016/S0301-0511(03)00107-8
35
VocatRPourtoisGVuilleumierP. Unavoidable errors: a spatio-temporal analysis of time-course and neural sources of evoked potentials associated with error processing in a speeded task. Neuropsychologia (2008) 46(10):2545–55.10.1016/j.neuropsychologia.2008.04.006
36
SchrijversDde BruijnERMaasYDe GraveCSabbeBGHulstijnW. Action monitoring in major depressive disorder with psychomotor retardation. Cortex (2008) 44(5):569–79.10.1016/j.cortex.2007.08.014
37
WaltherSHofleOFederspielAHornHHugliSWiestRet alNeural correlates of disbalanced motor control in major depression. J Affect Disord (2012) 136(1–2):124–33.10.1016/j.jad.2011.08.020
38
BenchCJFristonKJBrownRGFrackowiakRSDolanRJ. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med (1993) 23(3):579–90.10.1017/S0033291700025368
39
DolanRJBenchCJLiddlePFFristonKJFrithCDGrasbyPMet alDorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity?J Neurol Neurosurg Psychiatry (1993) 56(12):1290–4.10.1136/jnnp.56.12.1290
40
VidebechPRavnkildeBPedersenTHHartvigHEganderAClemmensenKet alThe Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatr Scand (2002) 106(1):35–44.10.1034/j.1600-0447.2002.02245.x
41
MilakMSParseyRVKeilpJOquendoMAMaloneKMMannJJ. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry (2005) 62(4):397–408.10.1001/archpsyc.62.4.397
42
DunnRTKimbrellTAKetterTAFryeMAWillisMWLuckenbaughDAet alPrincipal components of the Beck depression inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol Psychiatry (2002) 51(5):387–99.10.1016/S0006-3223(01)01244-6
43
MaybergHSLewisPJRegenoldWWagnerHNJr. Paralimbic hypoperfusion in unipolar depression. J Nucl Med (1994) 35(6):929–34.
44
MeyerJHKrugerSWilsonAAChristensenBKGouldingVSSchafferAet alLower dopamine transporter binding potential in striatum during depression. Neuroreport (2001) 12(18):4121–5.10.1097/00001756-200112210-00052
45
MeyerJHMcNeelyHESagratiSBoovariwalaAMartinKVerhoeffNPet alElevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study. Am J Psychiatry (2006) 163(9):1594–602.10.1176/ajp.2006.163.9.1594
46
EbertDFeistelHLoewTPirnerA. Dopamine and depression – striatal dopamine D2 receptor SPECT before and after antidepressant therapy. Psychopharmacology (1996) 126(1):91–4.10.1007/BF02246416
47
PericoCASkafCRYamadaADuranFBuchpiguelCACastroCCet alRelationship between regional cerebral blood flow and separate symptom clusters of major depression: a single photon emission computed tomography study using statistical parametric mapping. Neurosci Lett (2005) 384(3):265–70.10.1016/j.neulet.2005.04.088
48
Graff-GuerreroAGonzalez-OlveraJMendoza-EspinosaYVaugierVGarcia-ReynaJC. Correlation between cerebral blood flow and items of the Hamilton rating scale for depression in antidepressant-naive patients. J Affect Disord (2004) 80(1):55–63.10.1016/S0165-0327(03)00049-1
49
BrodyALSaxenaSMandelkernMAFairbanksLAHoMLBaxterLR. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry (2001) 50(3):171–8.10.1016/S0006-3223(01)01117-9
50
BeckerGBergDLeschKPBeckerT. Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings. Int J Neuropsychopharmacol (2001) 4(1):21–31.10.1017/S1461145701002164
51
BergDSupprianTHofmannEZeilerBJagerALangeKWet alDepression in Parkinson’s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol (1999) 246(12):1186–93.10.1007/s004150050541
52
BeckerGStruckMBogdahnUBeckerT. Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res (1994) 55(2):75–84.10.1016/0925-4927(94)90002-7
53
WalterUHoeppnerJPrudente-MorrisseyLHorowskiSHerpertzSCBeneckeR. Parkinson’s disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain (2007) 130(Pt 7):1799–807.10.1093/brain/awm017
54
WalterUPrudente-MorrisseyLHerpertzSCBeneckeRHoeppnerJ. Relationship of brainstem raphe echogenicity and clinical findings in depressive states. Psychiatry Res (2007) 155(1):67–73.10.1016/j.pscychresns.2006.12.001
55
BudisicMKarlovicDTrkanjecZLovrencic-HuzjanAVukovicVBosnjakJet alBrainstem raphe lesion in patients with major depressive disorder and in patients with suicidal ideation recorded on transcranial sonography. Eur Arch Psychiatry Clin Neurosci (2010) 260(3):203–8.10.1007/s00406-009-0043-z
56
BeckerTBeckerGSeufertJHofmannELangeKWNaumannMet alParkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry (1997) 63(5):590–6.10.1136/jnnp.63.5.590
57
HoeppnerJPrudente-MorrisseyLHerpertzSCBeneckeRWalterU. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency. Eur Arch Psychiatry Clin Neurosci (2009) 259(2):92–7.10.1007/s00406-008-0840-9
58
KupferschmidtDAZakzanisKK. Toward a functional neuroanatomical signature of bipolar disorder: quantitative evidence from the neuroimaging literature. Psychiatry Res (2011) 193(2):71–9.10.1016/j.pscychresns.2011.02.011
59
AdlerMLibergBAnderssonSIsacssonGHettaJ. Development and validation of the affective self rating scale for manic, depressive, and mixed affective states. Nord J Psychiatry (2008) 62(2):130–5.10.1080/08039480801960354
Summary
Keywords
psychomotor performance, major depressive disorder, neuroimaging, frontal lobe, basal ganglia, monoamines
Citation
Liberg B and Rahm C (2015) The Functional Anatomy of Psychomotor Disturbances in Major Depressive Disorder. Front. Psychiatry 6:34. doi: 10.3389/fpsyt.2015.00034
Received
19 December 2014
Accepted
19 February 2015
Published
10 March 2015
Volume
6 - 2015
Edited by
Sebastian Walther, University Hospital of Psychiatry, Switzerland
Reviewed by
Bernhard J. Mitterauer, Volitronics-Institute for Basic Research Psychopathology and Brain Philosophy, Austria; Jessica A. Turner, Georgia State University, USA; Sebastian Walther, University Hospital of Psychiatry, Switzerland
Copyright
© 2015 Liberg and Rahm.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Benny Liberg, Department of Psychiatry, Melbourne Neuropsychiatry Centre, Alan Gilbert Building, Level 3, 161 Barry Street, Carlton South, Melbourne, VIC 3053, Australia benny.liberg@gmail.com
Specialty section: This article was submitted to Schizophrenia, a section of the journal Frontiers in Psychiatry.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.